Title: Revolutionizing Pain Management: An Overview of Quantum Re-Generation Technology
In the realm of innovative and unique technologies, Quantum Re-Generation stands out as a groundbreaking solution in the field of pain treatment. This technology operates by targeting muscle pain and exerting decontracting action through the emission of high-tension depolarizing microcurrents.
This therapeutic action is rooted in the Gate Control Theory, allowing for the inhibition of nociceptive afferent transmission via small-diameter fibers. This is achieved through the use of pulsed microcurrents with a millisecond timeframe per impulse, acting on muscle tissue and exhibiting decontracting properties while increasing tissue oxygenation.
Quantum Re-Generation applies a procedure of electro-analgesia and neuro-modulation, with the ultimate goal of any analgesia technique being to inhibit the transmission of pain impulses using an electrical stimulus. The device comes with interchangeable tip attachments, making it suitable for treating small, localized areas like the temporomandibular joint or larger, extended areas like peripheral nerve canal syndrome such as sciatica.
The technology operates by using high-tension depolarizing microcurrents to inhibit pain signals by blocking nociceptors and promoting cellular regeneration. This is a form of electroralgesia, where external electrodes act on C-fibers (neurons specialized in slowly and deeply transmitting pain sensations) to provide a ‘counter-information.’
The analgesic effect is immediate, and as chronic pain reshapes neural circuits and creates ‘vicious circles’ that intensify suffering, repeated application of this therapy in a complete cycle of sessions can, in turn, reshape these altered sensory circuits, reducing hypersensitivity to pain.
To date, Quantum Re-Generation has been widely tested on patients with various painful musculoskeletal symptoms, neuropathic pain, and even oncologic pain in different pathologies.
After just one application, Quantum Re-Generation has proven extremely useful for patients with subacromial conflict syndrome and pain in the tendon of the supraspinatus and rotator cuff tendinitis. It has shown effectiveness in inhibiting the pain caused by plantar fasciitis generated by a calcaneal spur.
It has been positively tested on patients with degenerative joint arthrosis and pain, with limitations in function. All cervical, dorsal, lumbar, and sacro-coccygeal back pain has been treated. It has shown very positive results in rheumatoid arthritis and arthrosis of the hand, evidencing a clear reduction in pain with an increase in hand function.
Patients with chronic pain lasting over six months and acute pain from recent trauma, such as distortive ankle trauma, have shown positive results. Positive outcomes have also been achieved in the treatment of ligamentous and muscular issues, such as hip joint dysfunctions with pain and mobility limitations.
The technology has been tested on patients with temporal-mandibular disorder, pain in the masticatory muscles due to Bruxism and pain in the temporomandibular joint. In this type of patient, a significant reduction in pain and hypertonic muscle responsible for Bruxism has been observed.
The device has also been used in a case of neurological rigidity from Motor Neuron Disease, Sclerosis Laterale Amiotrophica. The patient exhibited a significant reduction in hypertonic muscle, leading to a significant improvement in walking ability.
Quantum Re-Generation has been used as an analgesic therapy in managing non-opioid-responsive oncologic pain, showing significant reductions in perceived pain levels. The treatment has been focused on painful metastatic bones after radiation therapy. The device has also been used in veterinary medicine, treating dogs with degenerative joint arthrosis in their legs. From the first treatment, the dog showed improved global mobility, indicating a significant reduction in pain. The device has been well tolerated and accepted by all patients, with no adverse effects reported by treated patients, who have all shown a significant reduction in pain.
